tiprankstipranks
Advertisement
Advertisement

BFRI Stock Latest News

Biofrontera’s Acne PDT Trial Completion: What Investors Should Watch Next
Company AnnouncementsBiofrontera’s Acne PDT Trial Completion: What Investors Should Watch Next
11d ago
BFRI
Biofrontera’s Phase III Actinic Keratosis Study Nears Data Payoff for Investors
PremiumCompany Announcements
Biofrontera’s Phase III Actinic Keratosis Study Nears Data Payoff for Investors
12d ago
BFRI
Biofrontera Shareholders Approve Director Elections and Equity Plan
PremiumCompany Announcements
Biofrontera Shareholders Approve Director Elections and Equity Plan
1M ago
8K
BFRI
Biofrontera Earnings Call Highlights Growth And Risks
PremiumCompany Announcements
Biofrontera Earnings Call Highlights Growth And Risks
2M ago
BFRI
StubHub, Jazz Pharmaceuticals upgraded: Wall Street’s top analyst calls
PremiumThe Fly
StubHub, Jazz Pharmaceuticals upgraded: Wall Street’s top analyst calls
2M ago
AMT
BAP
Biofrontera downgraded to Speculative Buy from Buy at Benchmark
PremiumThe FlyBiofrontera downgraded to Speculative Buy from Buy at Benchmark
2M ago
BFRI
Is BFRI a Buy, Before Earnings?
Premium
Pre-Earnings
Is BFRI a Buy, Before Earnings?
2M ago
BFRI
Biofrontera Earnings Call: Profits Rise, Risks Remain
Premium
Company Announcements
Biofrontera Earnings Call: Profits Rise, Risks Remain
4M ago
BFRI
Biofrontera reports Q4 revenue $17.1M vs. $12.6M last year
PremiumThe Fly
Biofrontera reports Q4 revenue $17.1M vs. $12.6M last year
4M ago
BFRI
Biofrontera, Inc. (BFRI) Q4 Earnings Cheat Sheet
PremiumPre-Earnings
Biofrontera, Inc. (BFRI) Q4 Earnings Cheat Sheet
4M ago
BFRI
Biofrontera Reports Positive Phase 2b Acne Trial Results
PremiumCompany Announcements
Biofrontera Reports Positive Phase 2b Acne Trial Results
4M ago
8K
BFRI
Biofrontera reports Phase 2b results of Ameluz PDT in acne vulgaris
PremiumThe Fly
Biofrontera reports Phase 2b results of Ameluz PDT in acne vulgaris
4M ago
BFRI
Biofrontera Wins Key PTAB Ruling in Sun Patent Dispute
PremiumCompany AnnouncementsBiofrontera Wins Key PTAB Ruling in Sun Patent Dispute
5M ago
8K
BFRI
Biofrontera reports USPTO decision on Sun Pharma’s challenged claims
Premium
The Fly
Biofrontera reports USPTO decision on Sun Pharma’s challenged claims
5M ago
BFRI
Biofrontera announces database lock of Phase 1 PK study of Ameluz
Premium
The Fly
Biofrontera announces database lock of Phase 1 PK study of Ameluz
5M ago
BFRI
Biofrontera announces FDA acceptance of sNDA for Ameluz PDT
PremiumThe Fly
Biofrontera announces FDA acceptance of sNDA for Ameluz PDT
5M ago
BFRI
Biofrontera Reports Positive Phase 3 Ameluz PDT Results
PremiumCompany Announcements
Biofrontera Reports Positive Phase 3 Ameluz PDT Results
5M ago
8K
BFRI
Biofrontera announces positive Phase 3 results for Ameluz PDT
PremiumThe Fly
Biofrontera announces positive Phase 3 results for Ameluz PDT
5M ago
BFRI
Biofrontera reports preliminary Q4 revenue $17M-$17.5M
PremiumThe Fly
Biofrontera reports preliminary Q4 revenue $17M-$17.5M
6M ago
BFRI
Biofrontera announces data base locks for two clinical studies
PremiumThe FlyBiofrontera announces data base locks for two clinical studies
6M ago
BFRI
Biofrontera Receives Nasdaq Notice on Bid Price Noncompliance
Premium
Company Announcements
Biofrontera Receives Nasdaq Notice on Bid Price Noncompliance
6M ago
8K
BFRI
Biofrontera completes transfer of Ameluz, RhodoLED FDA approval
Premium
The Fly
Biofrontera completes transfer of Ameluz, RhodoLED FDA approval
7M ago
BFRI

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >